237 related articles for article (PubMed ID: 32948514)
1. Self-administration of adrenaline for anaphylaxis during in-hospital food challenges improves health-related quality of life.
Burrell S; Patel N; Vazquez-Ortiz M; Campbell DE; DunnGalvin A; Turner PJ
Arch Dis Child; 2021 Jun; 106(6):558-563. PubMed ID: 32948514
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
O'B Hourihane J; Beyer K; Abbas A; Fernández-Rivas M; Turner PJ; Blumchen K; Nilsson C; Ibáñez MD; Deschildre A; Muraro A; Sharma V; Erlewyn-Lajeunesse M; Zubeldia JM; De Blay F; Sauvage CD; Byrne A; Chapman J; Boralevi F; DunnGalvin A; O'Neill C; Norval D; Vereda A; Skeel B; Adelman DC; du Toit G
Lancet Child Adolesc Health; 2020 Oct; 4(10):728-739. PubMed ID: 32702315
[TBL] [Abstract][Full Text] [Related]
3. Peanut oral immunotherapy in adolescents: study protocol for a randomized controlled trial.
Michaud E; Evrard B; Pereira B; Rochette E; Bernard L; Rouzaire PO; Gourdon-Dubois N; Merlin E; Fauquert JL
Trials; 2015 Apr; 16():197. PubMed ID: 25925398
[TBL] [Abstract][Full Text] [Related]
4. AR101 Oral Immunotherapy for Peanut Allergy.
; Vickery BP; Vereda A; Casale TB; Beyer K; du Toit G; Hourihane JO; Jones SM; Shreffler WG; Marcantonio A; Zawadzki R; Sher L; Carr WW; Fineman S; Greos L; Rachid R; Ibáñez MD; Tilles S; Assa’ad AH; Nilsson C; Rupp N; Welch MJ; Sussman G; Chinthrajah S; Blumchen K; Sher E; Spergel JM; Leickly FE; Zielen S; Wang J; Sanders GM; Wood RA; Cheema A; Bindslev-Jensen C; Leonard S; Kachru R; Johnston DT; Hampel FC; Kim EH; Anagnostou A; Pongracic JA; Ben-Shoshan M; Sharma HP; Stillerman A; Windom HH; Yang WH; Muraro A; Zubeldia JM; Sharma V; Dorsey MJ; Chong HJ; Ohayon J; Bird JA; Carr TF; Siri D; Fernández-Rivas M; Jeong DK; Fleischer DM; Lieberman JA; Dubois AEJ; Tsoumani M; Ciaccio CE; Portnoy JM; Mansfield LE; Fritz SB; Lanser BJ; Matz J; Oude Elberink HNG; Varshney P; Dilly SG; Adelman DC; Burks AW
N Engl J Med; 2018 Nov; 379(21):1991-2001. PubMed ID: 30449234
[TBL] [Abstract][Full Text] [Related]
5. Peanut gastrointestinal delivery oral immunotherapy in adolescents: Results of the build-up phase of a randomized, double-blind, placebo-controlled trial (PITA study).
Fauquert JL; Michaud E; Pereira B; Bernard L; Gourdon-Dubois N; Rouzaire PO; Rochette E; Merlin E; Evrard B;
Clin Exp Allergy; 2018 Jul; 48(7):862-874. PubMed ID: 29665158
[TBL] [Abstract][Full Text] [Related]
6. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.
Wasserman RL; Factor JM; Baker JW; Mansfield LE; Katz Y; Hague AR; Paul MM; Sugerman RW; Lee JO; Lester MR; Mendelson LM; Nacshon L; Levy MB; Goldberg MR; Elizur A
J Allergy Clin Immunol Pract; 2014; 2(1):91-6. PubMed ID: 24565775
[TBL] [Abstract][Full Text] [Related]
7. Anaphylaxis Refractory to intramuscular adrenaline during in-hospital food challenges: A case series and proposed management.
Alviani C; Burrell S; Macleod A; Edees S; Roberts G; Turner PJ; Erlewyn-Lajeunesse M
Clin Exp Allergy; 2020 Dec; 50(12):1400-1405. PubMed ID: 32997857
[TBL] [Abstract][Full Text] [Related]
8. Interaction Between Baseline Participant Factors and Treatment Effects Following Peanut Oral Immunotherapy.
Lloyd M; Loke P; Ashley S; Lozinsky AC; Orsini F; O'Sullivan M; Gold M; Quinn P; Metcalfe J; Tang MLK
J Allergy Clin Immunol Pract; 2024 Apr; 12(4):1019-1028.e2. PubMed ID: 38154554
[TBL] [Abstract][Full Text] [Related]
9. Epinephrine treatment is infrequent and biphasic reactions are rare in food-induced reactions during oral food challenges in children.
Järvinen KM; Amalanayagam S; Shreffler WG; Noone S; Sicherer SH; Sampson HA; Nowak-Wegrzyn A
J Allergy Clin Immunol; 2009 Dec; 124(6):1267-72. PubMed ID: 20004784
[TBL] [Abstract][Full Text] [Related]
10. Successful oral tolerance induction in severe peanut allergy.
Clark AT; Islam S; King Y; Deighton J; Anagnostou K; Ewan PW
Allergy; 2009 Aug; 64(8):1218-20. PubMed ID: 19226304
[TBL] [Abstract][Full Text] [Related]
11. Peanut Allergen Threshold Study (PATS): Novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy.
Hourihane JO; Allen KJ; Shreffler WG; Dunngalvin G; Nordlee JA; Zurzolo GA; Dunngalvin A; Gurrin LC; Baumert JL; Taylor SL
J Allergy Clin Immunol; 2017 May; 139(5):1583-1590. PubMed ID: 28238744
[TBL] [Abstract][Full Text] [Related]
12. Modified peanut oral immunotherapy protocol safely and effectively induces desensitization.
Bird JA; Feldman M; Arneson A; Dougherty I; Brown LS; Burk CM; Kulis M; Burks W; Gill M
J Allergy Clin Immunol Pract; 2015; 3(3):433-5.e1-3. PubMed ID: 25609341
[No Abstract] [Full Text] [Related]
13. Parent and child perception of quality of life in a randomized controlled peanut oral immunotherapy trial.
Reier-Nilsen T; Carlsen KCL; Michelsen MM; Drottning S; Carlsen KH; Zhang C; Borres MP; Håland G
Pediatr Allergy Immunol; 2019 Sep; 30(6):638-645. PubMed ID: 31013372
[TBL] [Abstract][Full Text] [Related]
14. Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy.
Fernandez-Rivas M; Vereda A; Vickery BP; Sharma V; Nilsson C; Muraro A; Hourihane JO; DunnGalvin A; du Toit G; Blumchen K; Beyer K; Smith A; Ryan R; Adelman DC; Jones SM
Allergy; 2022 Mar; 77(3):991-1003. PubMed ID: 34320250
[TBL] [Abstract][Full Text] [Related]
15. Peanut Allergy: New Advances and Ongoing Controversies.
Abrams EM; Chan ES; Sicherer S
Pediatrics; 2020 May; 145(5):. PubMed ID: 32303583
[TBL] [Abstract][Full Text] [Related]
16. Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial.
Fleischer DM; Greenhawt M; Sussman G; Bégin P; Nowak-Wegrzyn A; Petroni D; Beyer K; Brown-Whitehorn T; Hebert J; Hourihane JO; Campbell DE; Leonard S; Chinthrajah RS; Pongracic JA; Jones SM; Lange L; Chong H; Green TD; Wood R; Cheema A; Prescott SL; Smith P; Yang W; Chan ES; Byrne A; Assa'ad A; Bird JA; Kim EH; Schneider L; Davis CM; Lanser BJ; Lambert R; Shreffler W
JAMA; 2019 Mar; 321(10):946-955. PubMed ID: 30794314
[TBL] [Abstract][Full Text] [Related]
17. Severity and threshold of peanut reactivity during hospital-based open oral food challenges: An international multicenter survey.
Arkwright PD; MacMahon J; Koplin J; Rajput S; Cross S; Fitzsimons R; Davidson N; Deshpande V; Rao N; Lumsden C; Lacy D; Allen KJ; Vance G; Mwenechanya J; Fox AT; Erlewyn-Lajeunesse M; Mistry H; Hourihane JO
Pediatr Allergy Immunol; 2018 Nov; 29(7):754-761. PubMed ID: 30022517
[TBL] [Abstract][Full Text] [Related]
18. Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.
Chinthrajah RS; Purington N; Andorf S; Long A; O'Laughlin KL; Lyu SC; Manohar M; Boyd SD; Tibshirani R; Maecker H; Plaut M; Mukai K; Tsai M; Desai M; Galli SJ; Nadeau KC
Lancet; 2019 Oct; 394(10207):1437-1449. PubMed ID: 31522849
[TBL] [Abstract][Full Text] [Related]
19. Anaphylaxis to foods.
Roberts G
Pediatr Allergy Immunol; 2007 Sep; 18(6):543-8. PubMed ID: 17680912
[TBL] [Abstract][Full Text] [Related]
20. [Anaphylaxis in two children caused by peanut and nut allergies; recommendations for treatment].
Boeve MM; Rottier BL; Mandema J; Ríngs EH; Kieboom JK; Dubois AE
Ned Tijdschr Geneeskd; 2007 Mar; 151(10):602-6. PubMed ID: 17402653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
